SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-05-000896
Filing Date
2005-02-14
Accepted
2005-02-14 17:24:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 d548171_13g-a.txt SC 13G/A 21121
  Complete submission text file 0000919574-05-000896.txt   22785
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-47221 | Film No.: 05612746
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PORTER FELLMAN INC 100 PARK AVENUE SUITE 2120 NEW YORK NY 10017
Business Address
PORTER A ALEX (Filed by) CIK: 0001120329 (see all company filings)

Type: SC 13G/A